High concentrations of catecholamines selectively diminish the sensitivity of CRF-stimulated ACTH release by cultured rat pituitary cells to the suppressive effects of dexamethasone

• Published in: Life sciences (1973) Vol. 39; no. 2; p. 97
• Main Authors: Lamberts, S W, Bons, E, Zuiderwijk, J
• Format: Journal Article
• Language: English
• Published: Netherlands 14.07.1986
• Subjects: Adrenocorticotropic Hormone - metabolism; Animals; Arginine Vasopressin - pharmacology; Catecholamines - pharmacology; Cells, Cultured; Corticotropin-Releasing Hormone - pharmacology; Dexamethasone - pharmacology; Drug Interactions; Epinephrine - pharmacology; Norepinephrine - pharmacology; Pituitary Gland - metabolism; Rats; Secretory Rate - drug effects; Vasoactive Intestinal Peptide - pharmacology
• ISSN: 0024-3205
• DOI: 10.1016/0024-3205(86)90442-X

ACTH-release by primary cultures of rat anterior pituitary cells in response to CRF, vasopressin, epinephrine, norepinephrine and VIP is readily suppressible by dexamethasone. Rat hypothalamic extract-induced ACTH release is less sensitive to the inhibitory effect of dexamethasone than that elicited by CRF and the other secretagogues mentioned above. In studying the additive and potentiating effect on ACTH release of CRF in combination with vasopressin, VIP and the catecholamines it became evident that only the combination of micromolar concentrations of epinephrine or norepinephrine together with nanomolar concentrations of CRF will make ACTH release significantly less sensitive to the suppressive effect of dexamethasone. Other combinations of CRF and vasopressin or CRF and VIP will render ACTH release as suppressible to dexamethasone, as that elicited by each of these compounds by itself. This observation in the rat might explain at least in part the observation that a diminished suppressibility of the pituitary-adrenal axis to dexamethasone can be found in patients with psychiatric disease, especially depression.